Taysha Gene Therapies (TSHA) Debt Ratio (2020 - 2026)

Taysha Gene Therapies has reported Debt Ratio for 7 years, with the latest figure at 0.16 in Q1 2026.

• Quarterly Debt Ratio fell 46.87% year-over-year to 0.16 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.16 (down 46.87% YoY) and the FY2025 annual result came in at 0.15, down 46.74% from the prior year.
• Debt Ratio improved to 0.16 in Q1 2026 per TSHA's latest filing, from 0.15 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.47 in Q2 2023 and troughed at 0.12 in Q2 2025.
• A 5-year average of 0.25 and a median of 0.24 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio surged 193.69% in 2022, then slumped 59.86% in 2024.
• Over 5 years, Debt Ratio stood at 0.3 in 2022, then dropped by 22.0% to 0.23 in 2023, then grew by 16.84% to 0.27 in 2024, then plunged by 46.74% to 0.15 in 2025, then climbed by 11.69% to 0.16 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.16, 0.15, and 0.16 for Q1 2026, Q4 2025, and Q3 2025 respectively.